JAN News and Press, JanOne Inc. From 08/25/23

JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting PR Newswire Abstract explained Jan101's statistically significant reduction in pain and improvement in nerve conduction velocity in prior Phase II study. LAS VEGAS ...

JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules PR Newswire LAS VEGAS , Aug. 22, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN) (the "Company"), a biopharmaceutical company specializing in developing non-addicting pa...

JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules PR Newswire LAS VEGAS , Aug. 18, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN) (the "Company"), a biopharmaceutical company specializing in developing non-addicting pain ...

JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting PR Newswire JAN101 Showed Statistically Significant Reduction in Pain and Improvement in Nerve Conduction Velocity in Prior Phase II study. ...

JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain PR Newswire Patent filing marks another milestone in becoming a world leader in pain management LAS VEGAS , June 28, 2023 /PRNewswire/ -- JanOne I...

JanOne Completes Pre-IND Meeting with FDA on Jan123 PR Newswire Company now has pathway toward formal drug application LAS VEGAS , April 18, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), the biopharmaceutical innovator specializing in non-addicting painkille...

JanOne to Present Data On Its Two Non-Opioid Drug Candidates at The Appalachian Region Spine and Pain Meeting on Drug Development Programs to Treat Pain on April 15, 2023 PR Newswire LAS VEGAS , April 13, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), Dr. Amol...

2023-04-06 10:11:48 ET Shares of clinical-stage biotech Janux Therapeutics ( NASDAQ: JANX ) inched higher Thursday after Wedbush launched its coverage with an Outperform recommendation, citing the potential of its platform technology. Janux ( JANX ) develops immunotherapies ...

2023-03-27 13:14:04 ET Gainers: Berkshire Grey ( BGRY ) +19% . Nuburu ( BURU ) +13% . ShiftPixy ( PIXY ) +9% . Perma-Fix Environmental Services ( PESI ) +8% . Quest Resource Holding Corporation ( QRHC ) +8% . Losers: ...

JanOne Technologies Announces Closing of Registered Direct Offering of Common Stock Priced At-The-Market PR Newswire LAS VEGAS , March 24, 2023 /PRNewswire/ -- JanOne (Nasdaq: JAN), a biopharmaceutical company specializing in developing non-addicting pain ki...